CLEARWATER, FL, November 25, 2009 /24-7PressRelease/ — Brain cancer is one of the deadliest forms of cancer. One person is diagnosed with it every three minutes, and the median survival time from discovery to death is 14.6 months. On…
{ 0 comments }
Posts tagged as:
chemotherapy agents
November 19, 2009 (FinancialWire) Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) announced clinical trial results related to Thresholds clinical stage hypoxia-activated prodrug, TH-302. The results were presented yesterday at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics being held November…
{ 0 comments }
/EIN News/ Budapest, Hungary – NanGenex Inc. (formerly known as ComErgen), a spin-off company of ThalesNano today announced the global launch of its revolutionary NanoActiveTM continuous flow nanoformulation technology. “The NanoActiveTM technology provides nanoformulation solutions for original as well as…
{ 0 comments }
